GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 320 filers reported holding GW PHARMACEUTICALS PLC in Q4 2019. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $9,472,000 | +1117.5% | 82,071 | +823.7% | 0.02% | +300.0% |
Q1 2020 | $778,000 | -74.5% | 8,885 | -69.5% | 0.01% | -68.8% |
Q4 2019 | $3,050,000 | -53.1% | 29,164 | -48.4% | 0.02% | -61.0% |
Q3 2019 | $6,506,000 | +6.7% | 56,556 | +59.9% | 0.04% | 0.0% |
Q2 2019 | $6,098,000 | +47.3% | 35,375 | +44.0% | 0.04% | +70.8% |
Q1 2019 | $4,141,000 | -60.9% | 24,567 | -77.4% | 0.02% | -64.2% |
Q4 2018 | $10,579,000 | -68.8% | 108,635 | -44.6% | 0.07% | -54.7% |
Q3 2018 | $33,858,000 | – | 196,000 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |